OUR PEOPLE

WORK EXPERIENCE:
Apr. 2025- Soei Patent & Law Firm
2008-2025 OHNO & PARTNERS (concurrent Visiting Professor of Tohoku University (2008-2021) and Visiting Senior Research Fellow, TRI, FBRI (2016-2023))
2001-2008 HIRAKI & ASSOCIATES
1988- 2001 Shiseido Company, Limited, Pharmaceutical Division, Licensing Group, and Patent Department
EDUCATION:
Mar. 1988 Master of Pharmaceutical Sciences (Immunology) The University of Tokyo (Graduate School of Pharmaceutical Sciences)
Mar. 1986 Bachelor of Pharmaceutical Sciences, The University of Tokyo (Faculty of Pharmaceutical Sciences)

PUBLICATIONS
Publications (Books):
◆"The point of intellectual property right lawsuit (知的財産権訴訟要論)" (Patent), 7th Edit.
Minoru TAKEDA/Yuko MATSUTOYA, 2017 December, JIII
ISBN 978‐4‐8271‐1292‐4
◆ "Medicine and Patent (医療と特許)" IIP Research Journal, Soeisha/Sanseido, 2017 April
The ways of Patent Protection of Medical Invention/Yuko MATSUTOYA
ISBN 978-4-88142-126-0
◆ “Working of the patented invention for experimental or research purposes”
Judge Makiko TAKABE’s retirement commemorative theses “Chitekizaisanken-sosho no kirameki” (The Glimmer of Intellectual Property Litigation), 2021 December, pp54-74

Publications (Law Review Articles):
◆ “Patentability of Product Claim reciting “Effect” as Element of Invention”
Intellectual Property Management, Vol.83 No.6 (No.870), pp678-689, 2023 June
◆ "Issues in patent law regarding CRISPR/Cas9 Patents - (3) Licensing and Patent pool"
The Invention Vo.116 No.2, pp65-69, 2019 February
◆ "Issues in Patent Law regarding CRISPR/Cas9 Patents - (2) Priority under Paris Convention"
The Invention Vo.116 No.1, pp47-51, 2019 January
◆ "Gene Editing Tool CRISPR/Cas9 - Patent and Licensing Issues"
LES JAPAN NEWS Vol.59 No.4, pp19-28, 2018 December
◆ "Issues in patent law regarding CRISPR/Cas9 patents - (1) First-to-file and Disclosure"
The Invention Vol.115 No.12, pp37-41, 2018 December
◆ "Regenerative medicine peripheral technology- IP of reagent and medium"
Pharm stage Vol.16 No.4, 2016 July
◆ "The status of IP in stem cell therapy: How to deal with patent infringement problem"
Clinical Evaluation, Vol.40, Suppl XXXI 2012
◆ "IP Relay - Should genes be patentable subject matter? - Myriad v. AMP"
Pharm stage Vol.10 No.11, 2011 February, Yuko MATSUTOYA・Ryan B. Chirnomas）
◆ "[Discussion] Trilateral comparison in examination of stem cell patent applications"
Patent, Vol.62 No.8, 2009 July, Joint-Paper
◆ "International competitiveness and patent strategy in iPS cell technologies"
Journal of Intellectual Property Association of Japan, 6th Annual Meeting, 2008, Masaho ISHINO/Yuko MATSUTOYA etc.